New pediatric asthma yardstick has treatment guidance for children of every age

July 9, 2018, American College of Allergy, Asthma, and Immunology

Although about 10 percent of school-aged children in the United States have asthma, there are few comprehensive U.S. guidelines for treating pediatric asthma. The Pediatric Asthma Yardstick, a new guideline from the American College of Allergy, Asthma and Immunology (ACAAI), offers a user-friendly "operational document". It helps health care professionals understand which controller treatments are right for which age groups and identifies when a step up is needed.

"There is nothing like the Pediatric Asthma Yardstick in the current literature," says allergist Bradley Chipps, MD, ACAAI president and lead author of the paper. "We created the yardstick because there are many options for treating pediatric . It's a roadmap for how to move forward with kids whose asthma is not under control. The yardstick describes controller treatments at different levels of severity for all ages, the choices available for parents for their child and how to step up therapy."

The diagnosis and management of asthma in differs from that in adults. Differences also exist between the three age groups addressed in the yardstick—adolescents, 12-18 years old; school-age children, 6-11 years old; infants and young children, 5 years old and under.

"Differences in diagnosis and management of asthma in children reflect differences in development of their respiratory systems, particularly for younger children," says Leonard Bacharier, MD, co-author of the yardstick. "Other factors include challenges related to daily activities and emotional and social concerns, particularly for adolescents. Comorbid conditions and non-adherence with treatment (eg; due to the stigma of having a chronic condition and taking medicine) can affect outcomes for older children."

Although asthma often begins in early childhood, diagnosing asthma in the very young child is challenging because it is based largely on symptoms and is not easily confirmed by objective testing, such as lung function. Additionally, symptoms, notably wheezing and coughing, often are related to, or occur with, common viral infections. Pediatric data for medicines are limited and robust clinical studies attesting to efficacy and safety of asthma medications are few.

"The Pediatric Asthma Yardstick is a practical resource for identifying children with uncontrolled asthma who need a step-up in controller medicine," says Dr. Chipps. "It describes how to start and/or adjust controller therapy based on the options that are currently available for children, from infants to 18 years of age. The recommendations are presented around patient profiles, by severity and age, and are based on current best practice strategies according to the most recent data and the authors' clinical experience."

Explore further: New asthma tool determines best treatment for severe asthma patients

More information: Bradley E. Chipps et al. The pediatric asthma yardstick, Annals of Allergy, Asthma & Immunology (2018). DOI: 10.1016/j.anai.2018.04.002

Related Stories

New asthma tool determines best treatment for severe asthma patients

June 19, 2018
One in 12 adults and one in 11 children in the United States are living with asthma, according to the Centers for Disease Control and Prevention (CDC). The communication between patients and clinicians is an important factor ...

Clinicians need a clear definition of severe asthma for precise management

November 14, 2017
Those who treat patients suffering with severe asthma know how frustrating it can be to try to get the disease under control - despite the introduction in recent years of both biologics and bronchial thermoplasty. These treatments ...

Teens with asthma almost twice as likely to smoke as their healthy counterparts

November 11, 2016
Curiosity is a driving factor in why most kids start smoking, and the same is true for kids with asthma. A study presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting found ...

Study shows improving pediatric asthma care is possible

March 2, 2018
Pediatric asthma is the most common chronic childhood condition and a leading cause of pediatric hospital admissions.

Asthma management tools improve asthma control and reduce hospital visits

March 13, 2018
A set of comprehensive asthma management tools helps decrease asthma-related visits to the emergency department, urgent care or hospital and improves patients' asthma control.

Breastfeeding may help prevent children's asthma exacerbations later in life

September 1, 2017
In a Pediatric Allergy and Immunology analysis of children with asthma, those who had been breastfed had a 45 percent lower risk of asthma exacerbations later in life compared with children who had not been breastfed.

Recommended for you

Immunity connects gut bacteria and aging

November 13, 2018
Over the years, researchers have learned that the different populations of bacteria that inhabit the gut have significant effects on body functions, including the immune system. The populations of gut bacteria are sometimes ...

An enzyme in immune cells plays essential role in host defense against tuberculosis

November 13, 2018
Using freshly resected lung tissue from 21 patients and two distinct mouse models, tuberculosis researchers at the University of Alabama at Birmingham and the Africa Health Research Institute, or AHRI, have identified a protein ...

Probiotics increase bone volume in healthy mice

November 13, 2018
A widely-used probiotic stimulates bone formation in young female mice, according to a study published November 13th in the journal Immunity. In response to treatment with Lactobacillus rhamnosus GG (LGG), other intestinal ...

Study shows changes in histone methylation patterns in nutritionally stunted children

November 13, 2018
An international team of researchers has found changes in histone methylation patterns in nutritionally stunted children. In their paper published in Proceedings of the National Academy of Sciences, the group describes their ...

New clues to the origin and progression of multiple sclerosis

November 13, 2018
Mapping of a certain group of cells, known as oligodendrocytes, in the central nervous system of a mouse model of multiple sclerosis (MS), shows that they might have a significant role in the development of the disease. The ...

Cognitive decline—radiation—brain tumor prevented by temporarily shutting down immune response

November 13, 2018
Treating brain tumors comes at a steep cost, especially for children. More than half of patients who endure radiation therapy for these tumors experience irreversible cognitive decline, a side-effect that has particularly ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.